Browse by Phase
Phase 1 Clinical Trials
Phase 1 trials test a new drug or treatment in a small group (20–80 people) for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects.
Total Trials
604
Recruiting Now
604
Top Conditions in Phase 1
NCT07260591 Phase 1
Recruiting
VSV-02 Compassionate Use in Advanced Solid Tumors
Condition
Advanced Solid Tumor
Enrollment
6 pts
Location
China
Sponsor
The First Affiliated Hospital
NCT05562024 Phase 1
Recruiting
TAA06 Injection in the Treatment of Patients With B7-H3-positive Relapsed/ Refra...
Condition
B7-H3-positive Relapsed/ Refractory Neuroblastoma
Enrollment
24 pts
Location
China
Sponsor
PersonGen BioTherapeutics (Suz
NCT06636123 Phase 1
Recruiting
GZ17-6.02 in Advanced CRPC After Progression on Anti-Androgen Therapy
Condition
Castration-resistant Prostate Cancer
Enrollment
30 pts
Location
United States
Sponsor
Virginia Commonwealth Universi
NCT06209359 Phase 1
Recruiting
Mechanisms of Diuretic Resistance in Heart Failure, Aim 3
Condition
Heart Failure
Enrollment
50 pts
Location
United States
Sponsor
Yale University
NCT07025759 Phase 1
Recruiting
Effects of Peripheral Magnetic Stimulation on Cortical Excitability in Healthy I...
Condition
Healthy Individuals
Enrollment
18 pts
Location
Brazil
Sponsor
Universidade Federal de Pernam
NCT07334080 Phase 1
Recruiting
ECC4703 Food Effect and Relative Bioavailability Study in Healthy Adult Particip...
Condition
Metabolic Dysfunction-Associated Steatohepatitis
Enrollment
72 pts
Location
Australia
Sponsor
Eccogene
NCT03114462 Phase 1
Recruiting
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryng...
Condition
Malignant Neoplasms of Respiratory and Intrathoracic Organs
Enrollment
11 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
NCT03988283 Phase 1
Recruiting
Neoepitope-based Personalized DNA Vaccine Approach in Pediatric Patients With Re...
Condition
Pediatric Recurrent Central Nervous System Tumors
Enrollment
7 pts
Location
United States
Sponsor
Washington University School o
NCT06440135 Phase 1
Recruiting
Ziftomenib Maintenance Post Allo-HCT
Condition
Acute Myeloid Leukemia
Enrollment
22 pts
Location
United States
Sponsor
Massachusetts General Hospital
NCT05412225 Phase 1
Recruiting
A Study of an Alternative Treatment Approach (Preoperative Radiotherapy, Then Ma...
Condition
Breast Cancer
Enrollment
60 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance
NCT06564389 Phase 1
Recruiting
FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Pati...
Condition
Healthy Participants
Enrollment
119 pts
Location
United States
Sponsor
Pfizer
NCT07372989 Phase 1
Recruiting
Nebulized Human Amniotic Fluid in Patients With Interstitial Lung Disease
Condition
Lung Diseases, Interstitial
Enrollment
50 pts
Location
United States
Sponsor
Maule Stem Cell Research Insti
NCT07412691 Phase 1
Recruiting
A Study to Evaluate the Safety of BG-A3004 in Healthy Participants and Patients ...
Condition
Skin Diseases
Enrollment
98 pts
Location
China
Sponsor
BeOne Medicines
NCT03326310 Phase 1
Recruiting
Selumetinib and Azacitidine in High Risk Chronic Blood Cancers
Condition
Chronic Myeloid Leukemia
Enrollment
18 pts
Location
United States
Sponsor
University of Chicago
NCT06714513 Phase 1
Recruiting
ID93+GLA-SE Vaccine Against Tuberculosis in Older Adults Aged 55-74
Condition
Tuberculosis, Pulmonary
Enrollment
144 pts
Location
South Korea
Sponsor
Quratis Inc.
NCT06010862 Phase 1
Recruiting
Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastati...
Condition
Gastric Cancer
Enrollment
36 pts
Location
China
Sponsor
Chongqing Precision Biotech Co
NCT06917742 Phase 1
Recruiting
A Study of CPTX2309 in Healthy Participants
Condition
Healthy Volunteers
Enrollment
38 pts
Location
Australia
Sponsor
Capstan Therapeutics
NCT06195891 Phase 1
Recruiting
Orca-T Following Chemotherapy and Total Marrow and Lymphoid Irradiation for the ...
Condition
Acute Lymphoblastic Leukemia
Enrollment
33 pts
Location
United States
Sponsor
City of Hope Medical Center
NCT05983523 Phase 1
Recruiting
A Study of PEP07 (Checkpoint Kinase 1 Inhibitor) in Patients with Advanced or Me...
Condition
Advanced Solid Tumor
Enrollment
54 pts
Location
Taiwan
Sponsor
PharmaEngine
NCT06575296 Phase 1
Recruiting
Revumenib for the Treatment of Acute Leukemia in Patients Post-Allogeneic Stem C...
Condition
Acute Leukemia
Enrollment
27 pts
Location
United States
Sponsor
City of Hope Medical Center
NCT06204003 Phase 1
Recruiting
Cannabinoids for Pain Management and Neuroprotection From Concussion
Condition
Healthy
Enrollment
35 pts
Location
Canada
Sponsor
University of Regina
NCT06960161 Phase 1
Recruiting
Exploring the Use of Phototherapy to Improve CPAP Compliance
Condition
Obstructive Sleep Apnea
Enrollment
30 pts
Location
Canada
Sponsor
University of Alberta
NCT02889666 Phase 1
Recruiting
A Randomised Trial of Chemotherapy Plus Surgery for Recurrent Non-Small Cell Lun...
Condition
Recurrent Non-small Cell Lung Cancer
Enrollment
500 pts
Location
China
Sponsor
Shanghai Jiao Tong University
NCT07077356 Phase 1
Recruiting
Application of mRNA Vaccine in Liver Transplantation for Hepatocellular Carcinom...
Condition
Hepatocellular Carcinoma (HCC)
Enrollment
15 pts
Location
China
Sponsor
West China Hospital
NCT07481383 Phase 1
Recruiting
A First-in-Human Study to Evaluate Implantable Iontophoresis Chemotherapy Delive...
Condition
Pancreatic Adenocarcinoma Non-resectable
Enrollment
12 pts
Location
United States
Sponsor
Continuity Biosciences, LLC